Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 384

1.

Assessment of intratumoral heterogeneity with mutations and gene expression profiles.

Sung JY, Shin HT, Sohn KA, Shin SY, Park WY, Joung JG.

PLoS One. 2019 Jul 16;14(7):e0219682. doi: 10.1371/journal.pone.0219682. eCollection 2019.

PMID:
31310640
Free Article
2.

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis.

Kim SH, Lee DE, Park B, Joo J, Joung JY, Seo HK, Lee KH, Chung J.

BMC Cancer. 2019 Jul 15;19(1):688. doi: 10.1186/s12885-019-5900-1.

PMID:
31307432
Free Article
3.

A cytosine deaminase for programmable single-base RNA editing.

Abudayyeh OO, Gootenberg JS, Franklin B, Koob J, Kellner MJ, Ladha A, Joung J, Kirchgatterer P, Cox DBT, Zhang F.

Science. 2019 Jul 11. pii: eaax7063. doi: 10.1126/science.aax7063. [Epub ahead of print]

PMID:
31296651
4.
5.

Acute and repeated toxicological study of Myelophil, an ethanol extract of a mixture of Astragali Radix and Salviae Miltiorrhizae Radix, in beagle dogs.

Joung JY, Lee JS, Cho JH, Lee DS, Son CG.

BMC Complement Altern Med. 2019 Jul 8;19(1):166. doi: 10.1186/s12906-019-2588-3.

6.

Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss.

György B, Nist-Lund C, Pan B, Asai Y, Karavitaki KD, Kleinstiver BP, Garcia SP, Zaborowski MP, Solanes P, Spataro S, Schneider BL, Joung JK, Géléoc GSG, Holt JR, Corey DP.

Nat Med. 2019 Jul;25(7):1123-1130. doi: 10.1038/s41591-019-0500-9. Epub 2019 Jul 3.

PMID:
31270503
7.

Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study.

Kwon WA, Joung JY, Lee JE, Choi SY, Kim SH, Seo HK, Lee KH, Kim CS.

Investig Clin Urol. 2019 May;60(3):195-201. doi: 10.4111/icu.2019.60.3.195. Epub 2019 Apr 18.

8.

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.

Park S, Joung JG, Min YW, Nam JY, Ryu D, Oh D, Park WY, Lee SH, Choi Y, Ahn JS, Ahn MJ, Park K, Sun JM.

J Immunother Cancer. 2019 May 16;7(1):128. doi: 10.1186/s40425-019-0609-x.

9.

Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.

Shin H, Sa JK, Bae JS, Koo H, Jin S, Cho HJ, Choi SW, Kyoung JM, Kim JY, Seo YJ, Joung JG, Kim NKD, Son DS, Chung J, Lee T, Kong DS, Choi JW, Seol HJ, Lee JI, Suh YL, Park WY, Nam DH.

Cancer Res Treat. 2019 May 7. doi: 10.4143/crt.2019.036. [Epub ahead of print]

10.

Fantatrope, a moving hologram display: design and implementation.

Gentet P, Joung J, Gentet Y, Hamacher A, Lee SH.

Opt Express. 2019 Apr 15;27(8):11571-11584. doi: 10.1364/OE.27.011571.

PMID:
31053000
11.

Correlation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal Ultrasonography.

Kim SH, Park B, Kwon WA, Joung JY, Seo HK, Chung J, Lee KH.

Biomed Res Int. 2019 Mar 31;2019:7029450. doi: 10.1155/2019/7029450. eCollection 2019.

12.

Single-Center Analysis of Human Papillomavirus Infection and P16INK4A Expression among Korean Patients with Penile Cancer.

Kwon WA, Yoon MY, Kim SH, Seo HK, Chung J, Lee KH, Joung JY, Park WS.

Biomed Res Int. 2019 Mar 26;2019:6940582. doi: 10.1155/2019/6940582. eCollection 2019.

13.

Impact of Genetic Variation on CRISPR-Cas Targeting.

Canver MC, Joung JK, Pinello L.

CRISPR J. 2018 Apr;1:159-170. doi: 10.1089/crispr.2017.0016.

PMID:
31021199
14.

Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.

Grünewald J, Zhou R, Garcia SP, Iyer S, Lareau CA, Aryee MJ, Joung JK.

Nature. 2019 May;569(7756):433-437. doi: 10.1038/s41586-019-1161-z. Epub 2019 Apr 17.

PMID:
30995674
15.

Comparison of Blue and Green Confocal Scanning Laser Ophthalmoscope Imaging to Detect Retinal Nerve Fiber Layer Defects.

Joung JY, Lee WJ, Lee BR.

Korean J Ophthalmol. 2019 Apr;33(2):131-137. doi: 10.3341/kjo.2018.0075.

16.

Covalently Linked Perylene Diimide-Polydiacetylene Nanofibers Display Enhanced Stability and Photocurrent with Reversible FRET Phenomenon.

Seo J, Kantha C, Joung JF, Park S, Jelinek R, Kim JM.

Small. 2019 May;15(19):e1901342. doi: 10.1002/smll.201901342. Epub 2019 Apr 10.

PMID:
30968560
17.

Banha-sasim-tang improves gastrointestinal function in loperamide-induced functional dyspepsia mouse model.

Jeon YJ, Lee JS, Cho YR, Lee SB, Kim WY, Roh SS, Joung JY, Lee HD, Moon SO, Cho JH, Son CG.

J Ethnopharmacol. 2019 Jun 28;238:111834. doi: 10.1016/j.jep.2019.111834. Epub 2019 Mar 30.

PMID:
30940567
18.

Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator.

Oh BY, Shin HT, Yun JW, Kim KT, Kim J, Bae JS, Cho YB, Lee WY, Yun SH, Park YA, Park YH, Im YH, Lee J, Joung JG, Kim HC, Park WY.

Sci Rep. 2019 Mar 14;9(1):4542. doi: 10.1038/s41598-019-41098-0.

19.

Adopt a moratorium on heritable genome editing.

Lander ES, Baylis F, Zhang F, Charpentier E, Berg P, Bourgain C, Friedrich B, Joung JK, Li J, Liu D, Naldini L, Nie JB, Qiu R, Schoene-Seifert B, Shao F, Terry S, Wei W, Winnacker EL.

Nature. 2019 Mar;567(7747):165-168. doi: 10.1038/d41586-019-00726-5. No abstract available.

PMID:
30867611
20.

CRISPResso2 provides accurate and rapid genome editing sequence analysis.

Clement K, Rees H, Canver MC, Gehrke JM, Farouni R, Hsu JY, Cole MA, Liu DR, Joung JK, Bauer DE, Pinello L.

Nat Biotechnol. 2019 Mar;37(3):224-226. doi: 10.1038/s41587-019-0032-3. No abstract available.

PMID:
30809026
21.

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.

Kim SH, Kim JK, Park EY, Joo J, Lee KH, Seo HK, Joung JY, Chung J.

PLoS One. 2019 Feb 20;14(2):e0211105. doi: 10.1371/journal.pone.0211105. eCollection 2019.

22.

A literature review for the mechanisms of stress-induced liver injury.

Joung JY, Cho JH, Kim YH, Choi SH, Son CG.

Brain Behav. 2019 Mar;9(3):e01235. doi: 10.1002/brb3.1235. Epub 2019 Feb 13. Review.

23.

Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.

Kleinstiver BP, Sousa AA, Walton RT, Tak YE, Hsu JY, Clement K, Welch MM, Horng JE, Malagon-Lopez J, Scarfò I, Maus MV, Pinello L, Aryee MJ, Joung JK.

Nat Biotechnol. 2019 Mar;37(3):276-282. doi: 10.1038/s41587-018-0011-0. Epub 2019 Feb 11.

PMID:
30742127
24.

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation.

Ha B, Cho KH, Lee KH, Joung JY, Kim YJ, Lee SU, Kim H, Suh YG, Moon SH, Lim YK, Jeong JH, Kim H, Park WS, Kim SH.

Radiat Oncol. 2019 Jan 10;14(1):4. doi: 10.1186/s13014-019-1210-7.

25.

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching.

Kim SH, Park EY, Joo J, Joung JY, Seo HK, Chung J, Lee KH.

Biomed Res Int. 2018 Dec 6;2018:4307207. doi: 10.1155/2018/4307207. eCollection 2018.

26.

Cytopathologic Features of Secretory Carcinoma of Salivary Gland: Report of Two Cases.

Kim YA, Joung JW, Lee SJ, Oh HK, Cho CH, Sung WJ.

J Pathol Transl Med. 2019 Jan;53(1):70-74. doi: 10.4132/jptm.2018.11.09. Epub 2018 Dec 28.

27.

Clear cell papillary renal cell carcinoma: A case report and review of the literature.

Kim SH, Kwon WA, Joung JY, Seo HK, Lee KH, Chung J.

World J Nephrol. 2018 Dec 17;7(8):155-160. doi: 10.5527/wjn.v7.i8.155.

28.
29.

CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data.

Hsu JY, Fulco CP, Cole MA, Canver MC, Pellin D, Sher F, Farouni R, Clement K, Guo JA, Biasco L, Orkin SH, Engreitz JM, Lander ES, Joung JK, Bauer DE, Pinello L.

Nat Methods. 2018 Dec;15(12):992-993. doi: 10.1038/s41592-018-0225-6. No abstract available.

30.

En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.

Ahn SJ, Joung J, Lee BR.

Am J Ophthalmol. 2019 Mar;199:71-81. doi: 10.1016/j.ajo.2018.11.003. Epub 2018 Nov 16.

PMID:
30448463
31.

A naphthoimidazolium-cholesterol derivative as a ratiometric fluorescence based chemosensor for the chiral recognition of carboxylates.

Zhang X, Ko G, Joung JF, Li M, Jeong Y, Swamy KMK, Lee D, Liu Y, Lee S, Park S, James TD, Yoon J.

Chem Commun (Camb). 2018 Nov 22;54(94):13264-13267. doi: 10.1039/c8cc06262e.

PMID:
30411739
32.

Author Correction: Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.

Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F.

Nat Protoc. 2019 Jul;14(7):2259. doi: 10.1038/s41596-018-0063-0.

PMID:
30349047
33.

Defining CRISPR-Cas9 genome-wide nuclease activities with CIRCLE-seq.

Lazzarotto CR, Nguyen NT, Tang X, Malagon-Lopez J, Guo JA, Aryee MJ, Joung JK, Tsai SQ.

Nat Protoc. 2018 Nov;13(11):2615-2642. doi: 10.1038/s41596-018-0055-0.

34.

Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer.

Kim SH, Park B, Joung JY, Chung J, Seo HK, Lee KH, Park WS.

Cancer Res Treat. 2019 Jul;51(3):910-918. doi: 10.4143/crt.2018.314. Epub 2018 Oct 2.

35.

Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.

Yun JW, Lee S, Ryu D, Park S, Park WY, Joung JG, Jeong J.

Transl Oncol. 2019 Jan;12(1):43-48. doi: 10.1016/j.tranon.2018.09.003. Epub 2018 Sep 25.

36.

A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia.

Kim SH, Park WS, Joung JY, Lee KH, Chung J, Seo HK.

Case Rep Urol. 2018 Sep 6;2018:1059349. doi: 10.1155/2018/1059349. eCollection 2018.

37.

Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors.

Lee B, Lee JW, Shim JH, Joung JG, Yun JW, Bae JS, Shin HT, Sung KW, Park WY.

Transl Oncol. 2018 Dec;11(6):1390-1397. doi: 10.1016/j.tranon.2018.08.013. Epub 2018 Sep 11.

38.

Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.

Jung H, Yoo HY, Lee SH, Shin S, Kim SC, Lee S, Joung JG, Nam JY, Ryu D, Yun JW, Choi JK, Ghosh A, Kim KK, Kim SJ, Kim WS, Park WY, Ko YH.

Oncotarget. 2018 Aug 28;9(67):32882. doi: 10.18632/oncotarget.26080. eCollection 2018 Aug 28.

39.

Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.

Jeong CW, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):150-158. doi: 10.1038/s41391-018-0088-z. Epub 2018 Sep 13.

PMID:
30214035
40.

In vivo CRISPR editing with no detectable genome-wide off-target mutations.

Akcakaya P, Bobbin ML, Guo JA, Malagon-Lopez J, Clement K, Garcia SP, Fellows MD, Porritt MJ, Firth MA, Carreras A, Baccega T, Seeliger F, Bjursell M, Tsai SQ, Nguyen NT, Nitsch R, Mayr LM, Pinello L, Bohlooly-Y M, Aryee MJ, Maresca M, Joung JK.

Nature. 2018 Sep;561(7723):416-419. doi: 10.1038/s41586-018-0500-9. Epub 2018 Sep 12.

41.

Discovery of widespread type I and type V CRISPR-Cas inhibitors.

Marino ND, Zhang JY, Borges AL, Sousa AA, Leon LM, Rauch BJ, Walton RT, Berry JD, Joung JK, Kleinstiver BP, Bondy-Denomy J.

Science. 2018 Oct 12;362(6411):240-242. doi: 10.1126/science.aau5174. Epub 2018 Sep 6.

42.

Elucidating the Role of Molecule-Electrode Interfacial Defects in Charge Tunneling Characteristics of Large-Area Junctions.

Kong GD, Jin J, Thuo M, Song H, Joung JF, Park S, Yoon HJ.

J Am Chem Soc. 2018 Sep 26;140(38):12303-12307. doi: 10.1021/jacs.8b08146. Epub 2018 Sep 14.

PMID:
30183277
43.

Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents among Herbal Medicines.

Lee G, Joung JY, Cho JH, Son CG, Lee N.

Evid Based Complement Alternat Med. 2018 Aug 12;2018:3412074. doi: 10.1155/2018/3412074. eCollection 2018. Review.

44.

Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer.

Moon SH, Kim J, Joung JG, Cha H, Park WY, Ahn JS, Ahn MJ, Park K, Choi JY, Lee KH, Kim BT, Lee SH.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):446-454. doi: 10.1007/s00259-018-4138-5. Epub 2018 Aug 25.

PMID:
30145701
45.

Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma.

Joung JW, Oh HK, Lee SJ, Kim YA, Jung HJ.

J Pathol Transl Med. 2018 Sep;52(5):323-330. doi: 10.4132/jptm.2018.07.21. Epub 2018 Aug 19.

46.

An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities.

Gehrke JM, Cervantes O, Clement MK, Wu Y, Zeng J, Bauer DE, Pinello L, Joung JK.

Nat Biotechnol. 2018 Nov;36(10):977-982. doi: 10.1038/nbt.4199. Epub 2018 Jul 30.

47.

The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients.

Kim SH, Kwon WA, Kim S, Joung JY, Seo HK, Lee KH, Chung J.

Jpn J Clin Oncol. 2018 Sep 1;48(9):835-840. doi: 10.1093/jjco/hyy098.

PMID:
30053128
48.

Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs.

Listgarten J, Weinstein M, Kleinstiver BP, Sousa AA, Joung JK, Crawford J, Gao K, Hoang L, Elibol M, Doench JG, Fusi N.

Nat Biomed Eng. 2018 Jan;2(1):38-47. doi: 10.1038/s41551-017-0178-6. Epub 2018 Jan 10.

49.

Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize.

Lee K, Zhang Y, Kleinstiver BP, Guo JA, Aryee MJ, Miller J, Malzahn A, Zarecor S, Lawrence-Dill CJ, Joung JK, Qi Y, Wang K.

Plant Biotechnol J. 2019 Feb;17(2):362-372. doi: 10.1111/pbi.12982. Epub 2018 Jul 22.

50.

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.

Dastidar S, Ardui S, Singh K, Majumdar D, Nair N, Fu Y, Reyon D, Samara E, Gerli MFM, Klein AF, De Schrijver W, Tipanee J, Seneca S, Tulalamba W, Wang H, Chai YC, In't Veld P, Furling D, Tedesco FS, Vermeesch JR, Joung JK, Chuah MK, VandenDriessche T.

Nucleic Acids Res. 2018 Sep 19;46(16):8275-8298. doi: 10.1093/nar/gky548.

Supplemental Content

Support Center